ORLANDO, Fla., Oct. 28, 2019 /PRNewswire/ -- AllianceRx Walgreens Prime, one of the nation's largest specialty and home delivery pharmacies, announced today it has named

ATLANTA, Oct. 28, 2019 /PRNewswire/ -- Pain Care Labs, an industry leader in noninvasive pain relief devices, announced today that it has received a $1.7 million grant from the

STOCKHOLM, Oct. 28, 2019 /PRNewswire/ -- Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in the Asia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® with Accuray's Radixact® Treatment D

TOLEDO, Ohio, Oct. 28, 2019 /PRNewswire/ -- Based on a comprehensive analysis of U.S.-based private ventures, the Entrepreneur Magazine's 360 list features organizations that demonstrate mastery of four metrics: innovation, growth, leadership, and impact. TelaCare Health Solutions, a national telemedicine software and service provider, was recognized for leveraging its p

NEW YORK, Oct. 28, 2019 /PRNewswire/ -- The reviews are in! New to market lifestyle and fitness brand BootySprout, (www.bootysprout.com/) is going viral with their at-home high resistanc

SOUTH SAN FRANCISCO, Calif., Oct. 28, 2019 /PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented new preclinical data on its lead program ORIC-101 – a selective and potent glucocorticoid receptor (GR) antagonist in Phase

DUBLIN, Oct. 28, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), today announced that its subsidiaries, Forest Laboratories, LLC, Forest Laboratories, Inc. and Forest Laboratories Holdings Ltd. (collectively "Forest") have reached a resolution with a plaintiff class of direct purchasers of Namenda, concluding the previously disclosed direct purchaser class actio

SAN FRANCISCO, Oct. 28, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will release its third quarter 2019 financial results on November 12, 2019, after the market close. The Company will host a conference call at

SOUTH SAN FRANCISCO, Calif., Oct. 28, 2019 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for

SAN DIEGO, Oct. 28, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Applicat